SCOTTSDALE, Ariz., - (http://www.financialnewsmedia.com News Alert) - RiceBran Technologies (NASDAQ: RIBT and RIBTW) (\"RBT\"), a global leader in the production and marketing of value added products derived from rice bran, today announced the release of a claims substantiation analysis of the health benefits of RBT\'s proprietary rice bran based ingredients conducted by Medicus Research.

RBT contracted Medicus Research, the premier contract research organization for the Dietary Supplement, Functional Foods and Botanical Drug industries, to perform a comprehensive analysis of independent studies conducted on behalf of RBT to substantiate numerous important health claims for its proprietary and process patented rice bran derivatives and products. - Independent clinical studies and research demonstrate benefits across numerous health and wellness categories including lowering cholesterol, reducing hyperglycemia and improving insulin levels and insulin sensitivity



The research from Medicus substantiates that RBT\'s RiBran(TM) and RiSolubles products reduce hyperglycemia; improves insulin levels and insulin sensitivity; and increases adiponectin levels. The research also cites scientific evidence indicating that the Company\'s RiFiber(TM) product reduces total cholesterol, LDL cholesterol and triglycerides; reduces absorption of cholesterol; and reduces plasma lipid and lipoprotein cholesterol.



The full report as well as links to clinical study findings can be found on RBT\'s home page at www.ricebrantech.com .



W. John Short, CEO & President of RBT commented, \"As the consumer package goods industry focuses billions of dollars on healthy whole food nutrition, the ability to provide ingredients that can result in important front of label claims for these new products differentiates RBT from our competitors. Medicus Research is widely considered to be the leading provider of research and clinical trials for healthy, natural products and functional foods. We are excited that the team at Medicus has substantiated the health benefits of our rice bran based products. We plan to pursue additional studies with Medicus going forward.\"



Dr. Jay Udani, co-founder and CEO of Medicus Research noted, \"RiceBran Technologies proprietary ingredients and the active components of these ingredients...